Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/30/2002 | WO2002042767A2 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
05/30/2002 | WO2002042766A2 A system and method for investigating the effect of chemical and other factors on cell movement |
05/30/2002 | WO2002042764A1 Materials for enhancing staining of biopolymers in matrices |
05/30/2002 | WO2002042747A1 Detection system |
05/30/2002 | WO2002042740A1 Automated mechanical stress assay for screening cleaning ingredients |
05/30/2002 | WO2002042737A2 Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
05/30/2002 | WO2002042735A2 Human kcr1 regulation of herg potassium channel block |
05/30/2002 | WO2002042734A2 Mems-based integrated magnetic particle identification system |
05/30/2002 | WO2002042732A2 A method to measure the activation state of signaling pathways in cells |
05/30/2002 | WO2002042498A2 Dual bead assays including optical biodiscs and methods relating thereto |
05/30/2002 | WO2002042497A2 Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids |
05/30/2002 | WO2002042493A1 Method of testing anticancer agent-sensitivity of tumor cells |
05/30/2002 | WO2002042492A2 Method for detecting protozoae of the genus naegleria |
05/30/2002 | WO2002042489A1 Methods involving a t cell protein tyrosine phosphatase |
05/30/2002 | WO2002042488A1 Detection of infections in liquid samples by detecting fatty acids present in the headspace associated with the liquid sample |
05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
05/30/2002 | WO2002042432A2 Epothilone resistant cell lines |
05/30/2002 | WO2002042427A2 Mass tags for quantitative analysis |
05/30/2002 | WO2002042417A2 Human erg2 potassium channel |
05/30/2002 | WO2002042416A2 Immunoassay for fish identification |
05/30/2002 | WO2002042414A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
05/30/2002 | WO2002042410A2 Process for trapping and confining microorganisms in air using water-soluble polymers |
05/30/2002 | WO2002042332A2 Truncated cd200 |
05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
05/30/2002 | WO2002042328A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
05/30/2002 | WO2002042322A2 Mammalian nuclear receptor cofactors cf7 and cf8 and methods of use |
05/30/2002 | WO2002042311A2 Biotin derivatives, methods for making same and uses thereof as vectors |
05/30/2002 | WO2002042267A2 Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine |
05/30/2002 | WO2002041992A2 Method for biochemical analysis and corresponding arrangement |
05/30/2002 | WO2002041973A1 Separating living particles of a gas under pressure |
05/30/2002 | WO2002041881A2 Repinotan kit |
05/30/2002 | WO2002041870A2 Production and use of a targeted diagnostic system |
05/30/2002 | WO2002041839A2 Assays for inhibitors of neuronal transport of alzheimer's amyloid precursor protein |
05/30/2002 | WO2002041784A2 Allergy test chamber |
05/30/2002 | WO2002041779A1 Blood testing apparatus |
05/30/2002 | WO2002022649A3 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity |
05/30/2002 | WO2002022648A3 Compositions and methods for inducing specific cytolytic t cell responses |
05/30/2002 | WO2002020736A9 Proteases |
05/30/2002 | WO2002018581A9 G-protein coupled receptors |
05/30/2002 | WO2002018438A9 Modified proteins, isolated novel peptides, and uses thereof |
05/30/2002 | WO2002016903A3 Microfluidic device and method with trapping of sample in carities having lids that can be opened or closed |
05/30/2002 | WO2002016333A3 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
05/30/2002 | WO2002012548A8 METHOD OF ANALYZING NFλB ACTIVITY |
05/30/2002 | WO2002004562A3 Fluorescein-based metal sensors, and methods of making and using the same |
05/30/2002 | WO2002004102A3 Membrane and method for making same with consistent wicking properties for lateral flow assays |
05/30/2002 | WO2002003062A3 Whole blood assay method |
05/30/2002 | WO2002003047A3 Method and apparatus for the detection of volatile products in a sample |
05/30/2002 | WO2002002807A8 Diagnosis of diseases associated with cell signalling |
05/30/2002 | WO2002002756A3 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
05/30/2002 | WO2001098784A3 Particles and their use in molecular imprinting |
05/30/2002 | WO2001098534A3 Matrix screening method |
05/30/2002 | WO2001094380A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
05/30/2002 | WO2001092857A3 Dual beam ftir methods and devices for analyte detection in samples of low transmissivity |
05/30/2002 | WO2001092580A3 Lyophilizable and enhanced compacted nucleic acids |
05/30/2002 | WO2001092565A8 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
05/30/2002 | WO2001089682A3 Device and method for addressing a microfluidic cartridge |
05/30/2002 | WO2001087919A3 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins |
05/30/2002 | WO2001081413A3 Isolated human transporter proteins, nucleic acids and uses thereof |
05/30/2002 | WO2001073443A3 Methods and compositions for the simultaneous detection of multiple analytes |
05/30/2002 | WO2001073440A3 Detection of diarrhoeogenic e.coli germs |
05/30/2002 | WO2001073030A3 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
05/30/2002 | WO2001069254A3 Visually detectable dye labelled biomolecules for analysis |
05/30/2002 | WO2001068704A3 G-protein coupled receptors |
05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
05/30/2002 | WO2001064877A3 Human schizophrenia gene |
05/30/2002 | WO2001046467A3 Fluorescent intensity assay for duplex and triplex nucleic acid hybridization in solution utilizing fluorescent intercalators |
05/30/2002 | WO2001045494A9 Pyrophosphatase stress-related proteins and methods of use in plants |
05/30/2002 | WO2001044816A3 Conformational and topological protein regulation |
05/30/2002 | WO2001043876A9 Devices and methods for making bioarrays |
05/30/2002 | WO2001042508A9 Methods and compositions relating to electrical detection of nucleic acid reactions |
05/30/2002 | WO2001042473A3 Device and method for accelerated hydration of dry chemical sensors |
05/30/2002 | WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
05/30/2002 | WO2001040306A9 Human antibodies as detection reagents |
05/30/2002 | WO2001036662A3 Hydrolytic enzyme substrates and assay method |
05/30/2002 | WO2001029063A8 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
05/30/2002 | WO2001011373A8 Difference detection methods using matched multiple dyes |
05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
05/30/2002 | WO2000077518A3 Methods and compositions for opsonophagocytic assays |
05/30/2002 | US20020066117 Transgenic animal and methods |
05/30/2002 | US20020065613 System, method and storage medium for predicting impact performance of painted thermoplastic |
05/30/2002 | US20020065612 System for assessing metal deterioration on maritime vessels |
05/30/2002 | US20020065609 Methods for the survey and genetic analysis of populations |
05/30/2002 | US20020065608 Analyzing molecular diversity by total pharmacophore diversity |
05/30/2002 | US20020065445 Isobutene polymerisation process |
05/30/2002 | US20020065398 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
05/30/2002 | US20020065397 Protecting therapeutic compositions from host-mediated inactivation |
05/30/2002 | US20020065396 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
05/30/2002 | US20020065292 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity |
05/30/2002 | US20020065277 Administering to an obese patient or a patient at risk of becoming obese therapeutically effective amount of compound that attenuates binding of agouti-related protein to melanocortin receptors |
05/30/2002 | US20020065237 SBHWSB1 polypeptides/polynucleotides produced by recombinant techniques; gene therapy; diagnostic tests; agonists; antagonists; "positional cloning"; sequence of Serine(S), Aspargine/Asparic Acid(W), Histidine (H) and Tryptophan (T) |
05/30/2002 | US20020065225 Methods of determining altered NDPK functions and the diagnosis of cystic fibrosis |
05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
05/30/2002 | US20020065217 Treatments which elevate functional glycosylated leptin transport factor, for controlling weight and obesity |
05/30/2002 | US20020065216 Novel method of diagnosing and treating gliomas |
05/30/2002 | US20020065210 DcR3 polypeptide, a TNFR homolog |